Depressive Symptoms and Incident Heart Failure in the Jackson Heart Study: Differential Risk Among Black Men and Women.

Dr. Emily O’Brien is Associate Professor in Population Health Sciences, Associate Professor in Neurology, Core Faculty Member at Duke-Margolis Center for Health Policy,  and Co-Director of Population Health Sciences at the Duke Clinical Research Institute. Her research focuses on comparative effectiveness, patient-centered outcomes, and pragmatic health systems research in cardiovascular and pulmonary disease. Her areas of expertise include: Epidemiology, Pragmatic Clinical Trials, and Clinical Decision Sciences. Dr. O’Brien received her PhD in Epidemiology from the University of North Carolina in Chapel Hill. As principal investigator for projects funded by the FDA, NIH, and PCORI, she has extensive experience working with diverse data sources including registries, epidemiologic cohorts, electronic health records, and administrative claims data. Dr. O’Brien teaches Analytic Methods in the Department of Population Health Sciences PhD program and has co-authored over 160 manuscripts in peer-reviewed journals on topics ranging from epidemiologic methods, comparative effectiveness, and pragmatic clinical trials. She is an associate editor for Circulation: Cardiovascular Quality and Outcomes, Chair of the AHA QCOR Scientific & Clinical Education Lifelong Learning Committee, social media editor for the Journal of the American Heart Association, and a fellow of the American Heart Association.

I am a cardiologist with a clinical and research interest in heart failure (going from Failure to Function), including advanced therapies such as cardiac transplantation and mechanical assist devices or “heart pumps."

I serve our group as Chief of the Heart Failure Section.

I became a heart failure cardiologist in order to help patients manage their chronic disease over many months and years. I consider myself strongly committed to compassionate patient care with a focus on quality of life and patient preference.

I am the Editor in Chief of the Journal of Cardiac Failure - The official journal of the Heart Failure Society of America.

My research interests are focused on treating co-morbid diseases in heart failure patients and improving outcomes across the cardiovascular spectrum through clinical trials and outcomes research. Below, you will find my specific research interests:

•     Cardiometabolic disease
•     Co-morbidity characterization (diabetes, sleep apnea, renal failure) in heart failure
•     Phenotypic characterization and risk prognostication of patients with heart failure
•     Role of surrogate and nonfatal endpoints in clinical heart failure trials
•     Biomarkers in heart failure
•     Novel pharmacological and non-pharmacological approaches to heart failure
•     Improving site-based heart failure research

LaShaunta Glover is an epidemiologist with expertise in cardiovascular, social, and genetic epidemiology. Her research focuses on evaluating and understanding the social determinants of health that exacerbate cardiovascular disease. Her research additionally focuses on exploring social-biological pathways to cardiovascular disease risk with specific focus on OMICs (e.g. epigenomics, proteomics, metabolomics), as a way to understand how social factors lead to upstream cardiovascular disease. Dr. Glover primarily utilizes data from longitudinal cohort studies to understand these associations and is passionate about investigating reasons for health disparities in populations.